Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00131443 · ClinicalTrials.gov registry record · Phase 2
Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
A Phase 2 study of Basilar Migraine, sponsored by Monarch Medical Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00131443 is a Phase 2 study of Basilar Migraine that has completed, run by Monarch Medical Research. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00131443, a Phase 2 study of Basilar Migraine, has completed, sponsored by Monarch Medical Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess the effectiveness and safety of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents.
Conditions Studied
Interventions
- DRUG Topiramate
Study Locations (1)
Virginia
- Monarch Medical Research - Child and Adolescent Neurology - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-02 |
| Est. Completion | 2006-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00131443
The ClinicalTrials.gov registry entry for NCT00131443 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Monarch Medical Research, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Basilar Migraine appearing as the primary indexed condition, and to 1 intervention - of which Topiramate is the first listed.
NCT00131443 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00131443 about?
NCT00131443 is a clinical study titled "Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine". The objective of this study is to assess the effectiveness and safety of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents.
What is the current status of trial NCT00131443?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2004-02. Estimated completion is 2006-08.
What conditions does trial NCT00131443 study?
This clinical trial studies the following conditions: Basilar Migraine.
What interventions are being tested in trial NCT00131443?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT00131443?
This trial is sponsored by Monarch Medical Research, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00131443 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.